School of Pharmaceutical Sciences, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, P. R. China.
Chem Biodivers. 2012 Jan;9(1):162-9. doi: 10.1002/cbdv.201100049.
In a study to evaluate the structural elements essential for the antidiabetic activity of flavonoids, we synthesized two series of flavonoids, 5,7-dihydroxyflavanones and 5,7-dihydroxyflavones. In a screening for potential antidiabetic activity, most of the flavonoids showed a remarkable in vitro activity, and compounds 1f, 2d, and 3c were significantly more effective than the positive control, metformin. The biological activity was mainly affected by structural modification at the ring B moiety of the flavonoid skeleton. The results suggest that 5,7-dihydroxyflavonoids can be considered as promising candidates in the development of new antidiabetic lead compounds.
在一项评估黄酮类化合物抗糖尿病活性的结构要素的研究中,我们合成了两类黄酮类化合物,5,7-二羟基黄酮和 5,7-二羟基黄酮。在筛选潜在的抗糖尿病活性的过程中,大多数黄酮类化合物表现出显著的体外活性,化合物 1f、2d 和 3c 的活性明显优于阳性对照药二甲双胍。生物活性主要受黄酮骨架环 B 部分的结构修饰影响。结果表明,5,7-二羟基黄酮类化合物可被视为开发新型抗糖尿病先导化合物的有前途的候选物。